Endometrial histology and biochemistry in climacteric women during oestrogen and oestrogen/progestogen therapy.
作者信息
Whitehead M I, King R J, McQueen J, Campbell S
出版信息
J R Soc Med. 1979 May;72(5):322-7. doi: 10.1177/014107687907200504.
Abstract
摘要
相似文献
1
Endometrial histology and biochemistry in climacteric women during oestrogen and oestrogen/progestogen therapy.
J R Soc Med. 1979 May;72(5):322-7. doi: 10.1177/014107687907200504.
2
Role of estrogens and progesterone in the etiology and prevention of endometrial cancer: review.
Am J Obstet Gynecol. 1983 Jul 15;146(6):696-707. doi: 10.1016/0002-9378(83)91014-1.
3
Assessment of oestrogen and progestin effects on epithelium and stroma from pre- and postmenopausal endometria.
J Steroid Biochem. 1981 Dec;15:175-81. doi: 10.1016/0022-4731(81)90273-9.
4
Transdermal estrogen with a levonorgestrel-releasing intrauterine device for climacteric complaints: clinical and endometrial responses.
Am J Obstet Gynecol. 1995 Jan;172(1 Pt 1):114-9. doi: 10.1016/0002-9378(95)90095-0.
5
Reduced incidence of endometrial cancer among postmenopausal women treated with progestogens.
J Am Geriatr Soc. 1979 Sep;27(9):389-94. doi: 10.1111/j.1532-5415.1979.tb01673.x.
6
The effect of transdermal oestradiol on bleeding pattern, hormonal profiles and sex steroid receptor distribution in the endometrium of Norplant users.
Hum Reprod. 1996 Oct;11 Suppl 2:115-23. doi: 10.1093/humrep/11.suppl_2.115.
7
Endometrial factors under treatment with oestrogen and oestrogen/progestogen combinations.
Postgrad Med J. 1978;54 Suppl 2:74-81.
8
Progestogen potency in oral contraceptive pills.
Am J Obstet Gynecol. 1987 Oct;157(4 Pt 2):1048-52. doi: 10.1016/s0002-9378(87)80130-8.
9
The modifying effect of progestogen on the response of the post-menopausal endometrium to exogenous oestrogens.
Postgrad Med J. 1978;54 Suppl 2:59-64.
10
Progestin receptor isoforms and prostaglandin dehydrogenase in the endometrium of women using a levonorgestrel-releasing intrauterine system.
Hum Reprod. 1998 May;13(5):1210-7. doi: 10.1093/humrep/13.5.1210.
引用本文的文献
1
Hormone replacement therapy for women previously treated for endometrial cancer.
Cochrane Database Syst Rev. 2018 May 15;5(5):CD008830. doi: 10.1002/14651858.CD008830.pub3.
2
Menopausal hormone therapy and risk of endometrial cancer.
J Steroid Biochem Mol Biol. 2014 Jul;142:83-9. doi: 10.1016/j.jsbmb.2013.05.001. Epub 2013 May 13.
3
Factors influencing the cognitive and neural effects of hormone treatment during aging in a rodent model.
Brain Res. 2013 Jun 13;1514:40-9. doi: 10.1016/j.brainres.2013.02.020. Epub 2013 Feb 16.
4
Estrogen and progesterone together expand murine endometrial epithelial progenitor cells.
Stem Cells. 2013 Apr;31(4):808-22. doi: 10.1002/stem.1337.
5
Effects of long-term treatment with estrogen and medroxyprogesterone acetate on synapse number in the medial prefrontal cortex of aged female rats.
Menopause. 2012 Jul;19(7):804-11. doi: 10.1097/gme.0b013e31824d1fc4.
6
Long-term use of continuous-combined estrogen-progestin hormone therapy and risk of endometrial cancer.
Cancer Causes Control. 2011 Dec;22(12):1639-46. doi: 10.1007/s10552-011-9840-6. Epub 2011 Sep 11.
7
Long-term postmenopausal hormone therapy and endometrial cancer.
Cancer Epidemiol Biomarkers Prev. 2010 Feb;19(2):475-83. doi: 10.1158/1055-9965.EPI-09-0712. Epub 2010 Jan 19.
8
Hormone replacement therapy and the endometrium.
J Clin Pathol. 2001 Jun;54(6):435-40. doi: 10.1136/jcp.54.6.435.
9
Bioequivalence assessment of three different estradiol formulations in postmenopausal women in an open, randomized, single-dose, 3-way cross-over study.
Eur J Drug Metab Pharmacokinet. 1999 Jan-Mar;24(1):47-53. doi: 10.1007/BF03190010.
10
Hormone replacement therapy in the aged. A state of the art review.
Drugs Aging. 1996 Mar;8(3):193-213. doi: 10.2165/00002512-199608030-00005.
本文引用的文献
1
PRECURSORS OF CORPUS CANCER. IV. ADENOMATOUS HYPERPLASIA AS STAGE O CARCINOMA OF THE ENDOMETRIUM.
Am J Obstet Gynecol. 1963 Nov 1;87:662-78.
2
The significance of a typical endometrial hyperplasia.
J Obstet Gynaecol Br Commonw. 1961 Aug;68:668-72. doi: 10.1111/j.1471-0528.1961.tb02789.x.
3
Pre-menopausal cystic hyperplasia and endometrial carcinoma.
J Obstet Gynaecol Br Emp. 1959 Apr;66(2):288-96. doi: 10.1111/j.1471-0528.1959.tb02009.x.
4
Preliminary observations on urinary oestrogen excretion in certain gynaecological disorders.
J Obstet Gynaecol Br Emp. 1959 Apr;66(2):177-211. doi: 10.1111/j.1471-0528.1959.tb01999.x.
5
Out-patient diagnostic curettage.
J Obstet Gynaecol Br Commonw. 1970 Nov;77(11):1043-6. doi: 10.1111/j.1471-0528.1970.tb03457.x.
6
Estradiol and 20alpha-dihydroprogesterone dehydrogenase activities in human endometrium during the menstrual cycle.
Endocrinology. 1974 Feb;94(2):419-23. doi: 10.1210/endo-94-2-419.
7
Letter: Oestrogens as a cause of endometrial carcinoma.
Br Med J. 1976 May 15;1(6019):1209-10. doi: 10.1136/bmj.1.6019.1209-b.
8
Letter: Oestrogens as a cause of endometrial carcinoma.
Br Med J. 1976 May 8;1(6018):1144-5. doi: 10.1136/bmj.1.6018.1144-a.
9
Effect of gestagen therapy upon 17beta-hydroxysteroid dehydrogenase in human endometrial adenocarcinoma.
J Endocrinol. 1975 Oct;67(1):131-2. doi: 10.1677/joe.0.0670131.
10
Association of exogenous estrogen and endometrial carcinoma.
N Engl J Med. 1975 Dec 4;293(23):1164-7. doi: 10.1056/NEJM197512042932302.
Zotero 插件